Recerca
Àrea 3
Endocrinologia ginecològica i reproducció humana
Factor d'impacte: mitjana: 3.34, total: 133.45
Articles de l'any 2010
Original
-
Added Value of Intraoperative Real-Time Imaging in Searches for Difficult-to-Locate Sentinel Nodes
Vidal-Sicart S, Paredes P, Zanon G, Pahisa J, Martinez-Roman S, Caparros X, Vilalta A, Rull R, Pons F
J NUCL MED. 2010; 51: 1219-1225. IF: 6.424 -
Prospective Evaluation of Carcinoembryonic Antigen (CEA) and Carbohydrate Antigen 15.3 (CA 15.3) in Patients with Primary Locoregional Breast Cancer
Molina R, Auge JM, Farrus B, Zanon G, Pahisa J, Munoz M, Torne A, Filella X, Escudero JM, Fernandez P, Velasco M
CLIN CHEM. 2010; 56: 1148-1157. IF: 6.263 -
Do Patients Lie? An Open Interview vs. a Blind Questionnaire on Sexuality
Castelo-Branco C, Palacios S, Ferrer-Barriendos J, Alberich X
J SEX MED. 2010; 7: 873-880. IF: 4.884 -
Colposcopy Prediction of Progression in Human Papillomavirus Infections With Minor Cervical Lesions
DelPino M, Torne A, Alonso I, Mula R, Masoller N, Fuste V, Ordi J
OBSTET GYNECOL. 2010; 116: 1324-1331. IF: 4.357 -
Day-5 inhibin B serum concentrations and antral follicle count as predictors of ovarian response and live birth in assisted reproduction cycles stimulated with gonadotropin after pituitary suppression
Penarrubia J, Peralta S, Fabregues F, Carmona F, Casamitjana R, Balasch J
FERTIL STERIL. 2010; 94: 2590-2595. IF: 3.97 -
Unintended pregnancy after long-term Essure microinserts placement
Arjona JE, Serrano JJ, Povedano B, Carrasco S, Castelo-Branco C
FERTIL STERIL. 2010; 94: 2793-2795. IF: 3.97 -
Thrombin activatable fibrinolysis inhibitor and clot lysis time in women with recurrent miscarriage associated with the antiphospholipid syndrome
Martinez-Zamora MA, Creus M, Tassies D, Bove A, Reverter JC, Carmona F, Balasch J
FERTIL STERIL. 2010; 94: 2437-2440. IF: 3.97 -
Primary squamous cell carcinoma of the vagina: human papillomavirus detection, p16INK4A overexpression and clinicopathological correlations
Fuste V, DelPino M, Perez A, Garcia A, Torne A, Pahisa J, Ordi J
HISTOPATHOLOGY. 2010; 57: 907-916. IF: 3.855 -
Longitudinal brain perfusion changes in near-term small-for-gestational-age fetuses as measured by spectral Doppler indices or by fractional moving blood volume
Cruz-Martinez R, Figueras F, Hernandez-Andrade E, Puerto B, Gratacos E
AM J OBSTET GYNECOL. 2010; 203: 0-0. IF: 3.278 -
The 'question mark' sign as a new ultrasound marker of tetralogy of Fallot in the fetus
Martinez JM, Gomez O, Bennasar M, Olivella A, Crispi F, Puerto B, Gratacos E
ULTRASOUND OBST GYN. 2010; 36: 556-560. IF: 3.154 -
Prenatal diagnosis of tuberous sclerosis and analysis using magnetic resonance spectroscopy
Sanz-Cortes M, Martinez JM, Bennasar M, Puerto B, Graracos E
ULTRASOUND OBST GYN. 2010; 36: 522-524. IF: 3.154 -
Contribution of intrapulmonary artery Doppler to improve prediction of survival in fetuses with congenital diaphragmatic hernia treated with fetal endoscopic tracheal occlusion
Cruz-Martinez R, Moreno-Alvarez O, Hernandez-Andrade E, Castanon M, Done E, Martinez JM, Puerto B, Deprest J, Gratacos E
ULTRASOUND OBST GYN. 2010; 35: 572-577. IF: 3.154 -
Accuracy of four-dimensional spatiotemporal image correlation echocardiography in the prenatal diagnosis of congenital heart defects
Bennasar M, Martinez JM, Gomez O, Bartrons J, Olivella A, Puerto B, Gratacos E
ULTRASOUND OBST GYN. 2010; 36: 458-464. IF: 3.154 -
Treatment persistence and compliance with a combination of calcium and vitamin D
Castelo-Branco C, Cortes X, Ferrer M
CLIMACTERIC. 2010; 13: 578-584. IF: 2.568 -
Clot lysis time and thrombin activatable fibrinolysis inhibitor in severe preeclampsia with or without associated antiphospholipid antibodies
Martinez-Zamora MA, Tassies D, Carmona F, Espinosa G, Cerverac R, Reverter JC, Balasch J
J REPROD IMMUNOL. 2010; 86: 133-140. IF: 2.519 -
Conjunctive p16(INK4a) Testing Significantly Increases Accuracy in Diagnosing High-Grade Cervical Intraepithelial Neoplasia
Bergeron C, Ordi J, Schmidt D, Trunk MJ, Keller T, Ridder R
AM J CLIN PATHOL. 2010; 133: 395-406. IF: 2.473 -
Osteopontin and alpha V beta 3 integrin as markers of endometrial receptivity: the effect of different hormone therapies
Casals G, Ordi J, Creus M, Fabregues F, Carmona F, Casamitjana R, Balasch J
REPROD BIOMED ONLINE. 2010; 21: 349-359. IF: 2.38 -
Comparative Study of Laparoscopically Assisted Radical Vaginal Hysterectomy and Open Wertheim-Meigs in Patients With Early-Stage Cervical Cancer Eleven Years of Experience
Pahisa J, Martinez-Roman S, Torne A, Fuste P, Alonso I, Lejarcegui JA, Balasch J
INT J GYNECOL CANCER. 2010; 20: 173-178. IF: 2.179 -
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
DeSanjose S, Quint WGV, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR, Vallejos CS, DeRuiz PA, Lima MA, Guimera N, Clavero O, Alejo M, Llombart-Bosch A, Cheng-Yang C, Tatti SA, Kasamatsu E, Iljazovic E, Odida M, Prado R, Seoud M, Grce M, Usubutun A, Jain A, Suarez GAH, Lombardi LE, Banjo A, Menendez C, Domingo EJ, Velasco J, Nessa A, Chichareon SCB, Qiao YL, Lerma E, Garland SM, Sasagawa T, Ferrera A, Hammouda D, Mariani L, Pelayo A, Steiner I, Oliva E, Meijer CJLM, Al-Jassar WF, Cruz E, Wright TC, Puras A, Llave CL, Tzardi M, Agorastos T, Garcia-Barriola V, Clavel C, Ordi J, Andujar M, Castellsague X, Sanchez GI, Nowakowski AM, Bornstein J, Munoz N, Bosch FX
LANCET ONCOL. 2010; 11: 1048-1056. IF: 14.47 -
Evaluation of tumor markers (HER-2/neu oncoprotein, CEA, and CA 15.3) in patients with locoregional breast cancer: prognostic value
Molina R, Auge JM, Escudero JM, Filella X, Zanon G, Pahisa J, Farrus B, Munoz M, Velasco M
TUMOR BIOL. 2010; 31: 171-180. IF: 1.94 -
Predicting Non-Sentinel Lymph Node Status in Breast Cancer Patients with Sentinel Lymph Node Involvement: Evaluation of Two Scoring Systems
Sanjuan A, Escaramis G, Vidal-Sicart S, Illa M, Zanon G, Pahisa J, Rubi S, Velasco M, Santamaria G, Farrus B, Munoz M, Garcia Y, Fernandez PL, Pons F
BREAST J. 2010; 16: 134-140. IF: 1.61 -
The role of intranasal estradiol spray in the management of moderate to severe vasomotor symptoms in menopausal women
Castelo-Branco C, Coloma JL
GYNECOL ENDOCRINOL. 2010; 26: 23-29. IF: 1.36 -
Contraception knowledge and sexual behaviour in secondary school students
Reina MF, Ciaravino H, Llovera N, Castelo-Branco C
GYNECOL ENDOCRINOL. 2010; 26: 479-483. IF: 1.36 -
Atherogenic metabolic profile in PCOS patients: role of obesity and hyperandrogenism
Castelo-Branco C, Steinvarcel F, Osorio A, Ros C, Balasch J
GYNECOL ENDOCRINOL. 2010; 26: 736-742. IF: 1.36 -
Endometrial stromal sarcoma. Is there a place for radiotherapy?
Valduvieco I, Rovirosa A, Colomo L, DeSanJuan A, Pahisa J, Biete A
CLIN TRANSL ONCOL. 2010; 12: 226-230. IF: 1.146 -
Feticide Followed by Mifepristone-Misoprostol Regimen for Midtrimester Termination of Pregnancy in Two Cases of Complete Placenta Previa
Borras A, Gomez O, Sanz M, Martinez JM, Puerto B
FETAL DIAGN THER. 2010; 28: 114-116. IF: 0.911
Revisió
-
Autoimmunity and Recurrent Pregnancy Losses
Cervera R, Balasch J
CLIN REV ALLERG IMMU. 2010; 39: 148-152. IF: 2.597 -
Periodontitis and osteoporosis: a systematic review
Martinez-Maestre MA, Gonzalez-Cejudo C, Machuca G, Torrejon R, Castelo-Branco C
CLIMACTERIC. 2010; 13: 523-529. IF: 2.568 -
Therapeutic options for postmenopausal female sexual dysfunction
Al-Azzawi F, Bitzer J, Brandenburg U, Castelo-Branco C, Graziottin A, Kenemans P, Lachowsky M, Mimoun S, Nappi RE, Palacios S, Schwenkhagen A, Studd J, Wylie K, Zahradnik HP
CLIMACTERIC. 2010; 13: 103-120. IF: 2.568 -
Menopause and aging Changes in the immune system-A review
Gameiro CM, Romao F, Castelo-Branco C
MATURITAS. 2010; 67: 316-320. IF: 2.093 -
Ageing and infertility: an overview
Balasch J
GYNECOL ENDOCRINOL. 2010; 26: 855-860. IF: 1.36 -
Comprehensive clinical management of hirsutism
Castelo-Branco C, Cancelo MJ
GYNECOL ENDOCRINOL. 2010; 26: 484-493. IF: 1.36
Editorials
-
Sentinel lymph node and neoadjuvant therapy in breast cancer
Munoz M, Pahisa J, Caparros FX, Vidal-Sicart S
REV ESP MED NUCL. 2010; 29: 319-320. IF: 0.765